期刊名称:JOURNAL OF CLINICAL ANESTHESIA
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
The Journal of Clinical Anesthesia (JCA) addresses all aspects of anesthesia practice, including anesthetic administration, pharmacokinetics, preoperative and postoperative considerations, coexisting disease and other complicating factors, cost issues, and similar concerns anesthesiologists contend with daily. Exceptionally high standards of presentation and accuracy are maintained.
The core of the journal is original contributions on subjects relevant to clinical practice, rigorously peer-reviewed. Highly respected international experts have joined together to form the Editorial Board, sharing their years of experience and clinical expertise. Specialized section editors cover the various subspecialties within the field. To keep your practical clinical skills current, the journal bridges the gap between the laboratory and the clinical practice of anesthesiology and critical care to clarify how new insights can improve daily practice.
JCA is now affiliated with the Society for Education in Anesthesia (SEA) and includes a special section featuring articles sponsored byt the SEA's Journal of Education in Perioperative Medicine.
Visit JCA Online at URL: http://www.elsevier.com/locate/jcaonline !
|
 |
Instructions to Authors
The Journal of Clinical Anesthesia (JCA) publishes definitive, peer-reviewed articles devoted to the clinical practice of anesthesia. The JCA should be a participant in continuing education of clinicians, forecast important issues and trends in anesthesia and foster responsible debate on controversial issues. As an international journal, it encourages cross-communication between different cultures, informing our readers about medical and sometimes non-medical journalism, and provides enjoyable reading. Advertising between the pages of editorial content is not permitted.
The editors of JCA welcome the submission of manuscripts devoted to the clinical practice of anesthesia. Statements contained therein are the responsibility of the author(s). Each manuscript is considered for publication with the following understandings: 1) All persons designated as authors should qualify for authorship. The order of authorship should be a joint decision of the co-authors. Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should be based only on a substantial contributions to (a) conception and design, or analysis and interpretation of data; and to (b) drafting the article or resizing it critically for important intellectual content; and on (c) final approval of the version to be published. Conditions (a), (b), and (c) must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author. 2) Ghostwriting: It is unacceptable for a person who lends the use of his or her name to a manuscript (whether or not a fee has been paid for the use of that name), when the manuscript has been written by another person/persons who do not identify themselves, their affiliation, or potential or real conflicts of interest. Therefore, ghostwritten articles will be immediately rejected. 3) None of the material in the manuscript has been published previously nor is any of the material currently under consideration for publication elsewhere (including tables, illustrations, etc.) in any other journal. The author should make a full statement to the editor about all submissions and previous reports that might be regarded as prior or duplicate publication of the same or very similar work (see Acceptable Secondary Publication section below). Copies of such material should be included in the submitted paper for the editors' review.
All manuscripts accepted for publication in JCA become the sole property of the publisher. The publisher reserves copyright and renewal in all published material, which may not be reproduced in any form without the written permission of the publisher. If a manuscript is accepted for publication, the author(s) will be asked to assign copyright to the publisher.
Acceptable Secondary Publication Secondary publication in the same or another language, especially in other countries, is justifiable, and can be beneficial, provided all of the following conditions are met: __ The authors have received approval from the editors of both journals; the editor concerned with secondary publication must have a photocopy, reprint, or manuscript of the primary version. __ The priority of the primary publication is respected by a publication interval of at least one week (unless specifically negotiated otherwise by both editors). __ The paper for secondary publication is intended for a different group of readers; an abbreviated version could be sufficient. __ The secondary version reflects faithfully the data and interpretations of the primary version. __ A footnote on the title page of the secondary version informs readers, peers, and documenting agencies that the paper has been published in whole or in part, and states the primary reference. A suitable foot note might read: "This article is based on a study first reported in [title of journal, with full reference]."
Permission for such secondary publication should be free of charge.
MANUSCRIPTS
- Send manuscripts by first-class mail to: David J. Cullen, M.D., M.S., Editor-in-Chief, Journal of Clinical Anesthesia, Department of Anesthesiology, St. Elizabeth's Medical Center, 736 Cambridge Street, Boston, MA 02135-2997; E-mail: jca@cchcs.org
- Provide a cover letter, signed by all authors, indicating the name, address, telephone, and FAX numbers of the individual to whom correspondence and questions should be directed. Include a statement in the cover letter that the contents have not been published elsewhere and the paper is not being submitted elsewhere. Also indicate that the manuscript has been read and approved by all co-authors.
- Submit four copies of each item: manuscript, references, tables, legends for illustrations, and illustrations.
- Arrange the manuscript in the following order: title page, abstract (structured abstract if the work is an Original contribution only), text, acknowledgments, references, tables, legends for illustrations, and illustrations.
- Text: Arrange the body of the manuscript in the following order: (Structured) Abstract, Introduction, Materials and Methods, Results, Discussion, with each component beginning on a new page.
- Number the pages in sequence, with the title page as page 1, the (structured) abstract as page 2, etc., with the page number in the upper right-hand corner.
- Double-space the manuscript and type it on 8.5 x 11 inch (21.5 x 28 cm) white bond paper with 1-inch (2.5 cm) margins on all four sides.
- In the cover letter, please indicate to which category of publication the author is submitting the article: Original Contribution, Editorial, Case Report, Grand Rounds, Pharmacologic Review, Special Article (history, art, politics, etc.), Letter to the Editor.
TITLE PAGE
- Give the first name, middle initial, and last name of all authors. List each author's highest academic degree and provide the study affiliation (i.e., all departments and institutions from which the manuscript originated). All authors must fully meet the criteria for authorship as defined in the uniform requirements for manuscripts submitted to medical journals or N Engl J Med 1997; 336:309-15.
- Provide the name and address of the corresponding author to whom reprint requests should be sent.
- Show the address of each author at the time of the study and include the present address if it differs.
- Provide a running title of up to 50 characters.
- Acknowledge grants, sponsors, and funding sources that provided direct financial support to the research work contained in the manuscript.
Use terms from the U.S. Library of Medicine's Medical Subject Headings (MeSH) Annotated Alphabetical List for indexing purposes in Index Medicus.ABSTRACT
For Original Contributions only, provide a structured abstract of up to 300 words that clearly states the following (use these subheadings): 1) Study Objective, 2) Design--that is, the type of study conducted, 3) Setting--in what setting did the study take place, 4) Patients--how many patients, what kinds of patients, and the nature of the patients who were studied, 5) Interventions--what interventions were done to the patients, 6) Measurements, 7) Main Results--the principal finding of interest, 8) Conclusions--based on the kinds of patients studied and the interventions used, what conclusions do the authors draw from the main findings of interest. Do not cite references or use abbreviations in the structured (or other) abstract. The structured abstract should provide key information and be informative on its own, although it should not include discussion of pros and cons, limitations or justifications of the study.
List up to six keywords applicable to the contents of the manuscript. The keywords will be used for indexing purposes.
TEXT
Start the text on a new page. Arrange the text into four parts:
- Introduction: The rationale for the study. Do not include an extensive literature review.
- Materials and Methods: A clear and precise description of the experiment and the subjects from whom the data were derived. If subjects were randomized, describe the methods of randomization used. Identify all drugs and chemicals used, dosages, and routes of administration. Define all statistical methods used and, if appropriate, statistical references. Identify the name and address of the statistician who reviewed the data, if appropriate.
- Results: A factual account of the study's findings. Present these as logically appropriate in text, tables, or illustrations; do not repeat in the text what is demonstrated in a table or illustration.
- Discussion: A summary emphasizing new and important aspects of the study's conclusions. Ensure that all conclusions are justified by the results of the study. Identify the implications of the findings and their limitations, including implications for future research. Look at the pros and cons of the methods and results. Compare the implications and limitations of these findings with those reported in other essential studies. State new hypotheses when warranted, but clearly label them as such. Recommendations, where appropriate, may be included.
- Computer Disks: Authors are encouraged to submit 3? HD/DD computer disk to the editorial office. Please observe the following criteria. Send only hard copy when first submitting your paper for acceptance and review. When your paper has been refereed, revised if necessary, and accepted, send a disk containing the final version with the final hard copy. Make certain that the disk and hard copy match exactly. Specify what software was used, including which release, e.g., WordPerfect 6.1. Specify what computer was used (IBM compatible PC, Apple Macintosh, etc.). The article file should include all textual material (text, references, tables, figure captions, etc.) and separate illustration files, if available. The file should follow the general instructions on style/arrangement and, in particular, the reference style of JCA as given below. The file should be single spaced and should use the wrap-around end-of-line feature, i.e., returns at the end of paragraphs only. Place two returns after every element, such as title, headings, paragraphs, figure and table callouts. Be sure to keep a back-up disk for reference and safety.
ACKNOWLEDGMENTS
Funding sources and corporate or institutional associations should be given on the title page. Acknowledgments to individuals who assisted with the study or with manuscript preparation, including statistical review, should appear just before the references. Type acknowledgments double-spaced on a separate page immediately following the text.
REFERENCES
References must be publicly available and verified by the authors and against the original documents. If the reference is not publicly available, refer to the material in a footnote within the text. Any references to published abstracts must be less than three years old. Number references sequentially in the order of their citation in the manuscript. Type the reference list double-spaced on pages separated from the text. Include all names unless the authors number seven or more; in that case, list three names followed by "et al." Do not use periods after authors' initials. Provide inclusive page numbers for journal articles and specific page citations for books. Identify abstracts and letters. Style references according to "International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals." N Engl J Med 1997;336:309-15.
- Journal citation: Eichhorn JH, Cooper JB, Cullen DJ, et al: Anesthesia practice standards at Harvard: a review. J Clin Anesth 1988;1:55-65.
- Book citation: Thompson T, Kanton B: Hormonal and metabolic considerations in the acutely ill patient, 2nd ed. New York, Timely Publications, 1987;115-25,209-301.
- Chapter in a book: Baldwin T: Effective infusion therapy. In: Pronter K, Baldwin T, Senthoff V (eds): Insulin Infusion System Delivery. Baltimore: Immediate Press Publishers, 1986;88-152.
TABLES
Type tables double-spaced on separate pages. If a table must be continued, use a second sheet and repeat all headings. Provide a title for each table. Abbreviations may be used to simplify a table; define all abbreviations in a single footnote. Number tables consecutively in the order of their first citation in the text. Identify statistical measures of variation such as standard deviation and standard error of the mean.
LEGENDS FOR ILLUSTRATIONS
Provide a full legend for each illustration. Type legends double-spaced on the same page(s) separate from the text. In the legend, identify and define all abbreviations, symbols, arrows, and illustration parts.
ILLUSTRATIONS
Submit three sets of professionally prepared glossy black and white 5" x 7" (12.7 x 17.3 cm) or 8" x 10" (20.3 x 25.4 cm) photographs for each illustration. Number illustrations sequentially according to their first appearance in the text. Affix a label to the back of each illustration indicating its number, the first author's name, and the top of the illustration. If photographs of persons are submitted, either the subjects must not be identifiable or their pictures must be accompanied by written permission to use the photograph. Under special circumstances, color photographs can be published at a rate agreed upon between the authors and the publishers.
PERMISSIONS AND CREDITS
Illustrations, tables, or lengthy quotations taken from published sources must be acknowledged with a full bibliographic citation. The author's and publisher's permission to reprint must be submitted as soon as the manuscript receives final acceptance for publication. One copy of any article not accepted for publication will be kept by the JCA in its files for six months.
DRUG AND CHEMICAL NAMES
Refer to drugs by their approved generic names. If trade names are used, the generic equivalent should be given parenthetically at first use. Identify compounds by their formal chemical name at first use; thereafter the trivial name may be used.
CONSENT
In all manuscripts reporting the results of human studies, a statement must appear in the Materials and Methods section indicating that approval was obtained from the institutional review board (IRB) and that all human subjects signed written informed consent. Cite in the text the full name of IRB. Do not identify human subjects or patients.
CONFLICT OF INTEREST
JCA expects all authors to disclose any commercial association that might pose a conflict of interest for submitted article(s). Funding sources and corporate or institutional associations must be acknowledged on the title page. In the cover letter accompanying the manuscript, provide the names of associations, consultancies, individual philanthropists, stock ownership, or other equity interest (e.g., patent or licensing arrangements). If the manuscript is accepted for publication, disclosure of this information will be discussed with the author(s).
ADDITIONAL INFORMATION
Direct questions to the editorial office at (617)789-3089 or 789-2782; Fax (617)562-7754; E-mail: jca@cchcs.org.
Editorial Board
Editor-in-Chief:
D.J. Cullen MD, Professor of Anesthesiology, Tufts University School of Medicine and Chairman, Department of Anesthesiology, St. Elizabeth's Medical Center, Boston, MA, USA
Senior Editors:
S. Gelman MD, PhD, Professor of Anesthesia, Harvard Medical School, and Chairman, Department of Anesthesia, Brigham and Women's Hospital, Boston, MA, USA E. Lowenstein MD, Professor of Anesthesia, Harvard Medical School, and Anesthetist-in-Chief, Beth Israel Hospital, Boston, MA, USA
Founding Editor-in-Chief:
R.J. Kitz MD
Special Contributing Editor:
L.D. Vandam MD, Professor Emeritus of Anesthesia, Harvard Medical School, and Anesthetist, Brigham and Women's Hospital, Boston, MA, USA
Managing Editor:
A.L. Macaulay BA, St. Elizabeth's Medical Center, Boston, MA, USA; Email: jca@cchcs.org
Statistical Consultant:
Y. Chang PhD, Boston, MA, USA
The International Board of Editors:
D.R. Bacon MD, MA, Rochester, MN, USA P.G. Barash MD, New Haven, CT, USA M. Brown MD, Detroit, MI, USA D.B. Carr MD, FABPM, Boston, MA, USA A. Casati MD, Milan, Italy P. Coriat MD, Paris, France C.J. Cot?/B> MD, Chicago, IL, USA G.J. Crosby MD, Boston, MA, USA J.H. Eichhorn MD, Jackson, MS, USA A.S. Evers MD, St. Louis, MO, USA A.B. Froese MD, FFARCS, Kingston, Ontario, Canada R.R. Gaiser MD, Philadelphia, PA, USA Z.N. Kain MD, New Haven, CT, USA C.P. Larson, Jr. MD, Los Angeles, CA, USA C.E. Laurito MD, Chicago, IL, USA B.A. Liang MD,JD, PhD, Malibu, CA, USA D.A. Lubarsky MD, Durham, NC, USA K.E. McGoldrick MD, New Haven, CT, USA J.H. Modell MD, Gainesville, FL, USA S. Morita MD, Chiba, Japan A. Perel MD, Tel Hashomer, Israel D.S. Prough MD, Galveston, TX, USA M.F. Roizen MD, Chicago, IL, USA S.H. Rosenbaum MD, New Haven, CT, USA A. Schubert MD, MBA, Cleveland, OH, USA J.W. Sear MA, BSc, Oxford, UK M.C. Stock, MD, FCCP FCCM, Chicago, IL, USA R. Tempelhoff MD, St. Louis, MO, USA J.H. Tinker MD, Omaha, NE, USA K.K. Tremper MD, PhD, Ann Arbor, MI, USA H. Van Aken PhD, MD, M黱ster, Germany T.S. Vitez MD, San Jose, CA, USA P.F. White PhD, MD, Dallas, TX, USA L. Wiklund MD, PhD, Uppsala, Sweden
|